134 related articles for article (PubMed ID: 8399632)
1. Dislipemia in patients undergoing continuous ambulatory peritoneal dialysis: pharmacological therapy (simvastatin) versus hemodialysis.
Marangoni R; Civardi F; Masi F; Cimino R; Maltagliati L; Romei Longhena G
Perit Dial Int; 1993; 13 Suppl 2():S431-3. PubMed ID: 8399632
[TBL] [Abstract][Full Text] [Related]
2. The effect of simvastatin on dyslipemia in continuous ambulatory peritoneal dialysis patients.
Dimitriadis A; Antoniou S; Hatzisavvas N; Pastore F; Kaldi I; Stangou M
Perit Dial Int; 1993; 13 Suppl 2():S434-6. PubMed ID: 8399633
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment].
Fiorini F; Patrone E; Ardu F; Castelluccio A
Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
[TBL] [Abstract][Full Text] [Related]
5. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
[TBL] [Abstract][Full Text] [Related]
6. Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
Li PK; Mak TW; Chiu K; Mak GY; Leung CB; Lui SF; Lam CW; Lai KN
Aust N Z J Med; 1993 Jun; 23(3):252-7. PubMed ID: 8352699
[TBL] [Abstract][Full Text] [Related]
7. [Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].
Zhu XP; Li J; Liu FY; Liu YH
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):154-6. PubMed ID: 12212206
[TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering effects of lovastatin in CAPD patients.
Jacobs RH; Lal SM; Nolph KD
Adv Perit Dial; 1993; 9():288-90. PubMed ID: 8105945
[TBL] [Abstract][Full Text] [Related]
9. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
10. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
Fiorini F; Patrone E; Castelluccio A
Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.
Di Paolo B; Del Rosso G; Catucci G; Vocino V; Terenzio MG; Bonomini M; Suriani K; Albertazzi A
ASAIO Trans; 1990; 36(3):M578-80. PubMed ID: 2252755
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin in CAPD patients with hypercholesterolemia.
De Vecchi A; Scalamogna A; Paparella M; Colombini M; Rovellini A; Pini C; Castelnovo C
Adv Perit Dial; 1992; 8():331-3. PubMed ID: 1361817
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.
Matthys E; Schurgers M; Lamberigts G; Lameire N; Vandecasteele N; Labeur C; Beisiegel U; Rosseneu M
Atherosclerosis; 1991 Feb; 86(2-3):183-92. PubMed ID: 1872912
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Am J Nephrol; 2001; 21(5):373-7. PubMed ID: 11684797
[TBL] [Abstract][Full Text] [Related]
16. Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group.
Walker RJ; Sutherland WH; Walker HL; MacMahon S; Robson RA
Nephrol Dial Transplant; 1997 Jan; 12(1):87-92. PubMed ID: 9027779
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
[TBL] [Abstract][Full Text] [Related]
18. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
20. Safe use of gemfibrozil in uremic patients on continuous ambulatory peritoneal dialysis.
Lucatello A; Sturani A; Di Nardo AM; Cocchi R; Fusaroli M
Nephron; 1998; 78(3):338. PubMed ID: 9546699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
